Genome Canada is delighted to welcome Rob Annan as Vice-President, Public Affairs and Communications, effective September 11, 2017.
In this role, Dr. Annan will drive an overarching strategy that promotes the value and potential of genomics in Canada to Genome Canada’s major stakeholders, while raising the public profile of Genome Canada both nationally and internationally.
Genome Canada is pleased to release its Annual Report 2016-17, Partnership – It’s In Our DNA.
Montreal scientists and their international colleagues have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease. Professor John D.
Leukemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukemia (AML) to rare therapy-resistant leukemia stem cells that are already present at diagnosis and before chemotherapy begins.
They have also identified two distinct stem-cell like populations from which relapse can arise in different patients in this aggressive cancer that they previously showed starts in blood stem cells in the bone marrow.
$33 million will drive scientific discoveries into potentially life-saving cures for patients
Government of Canada and partners support five new projects that will help scientists work with industry to address real-world challenges through genomics research